87 related articles for article (PubMed ID: 11598799)
1. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.
Bernhard D; Skvortsov S; Tinhofer I; Hübl H; Greil R; Csordas A; Kofler R
Cell Death Differ; 2001 Oct; 8(10):1014-21. PubMed ID: 11598799
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
Kim YH; Park JW; Lee JY; Kwon TK
Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
[TBL] [Abstract][Full Text] [Related]
6. Synergistic apoptosis induction by proteasome and histone deacetylase inhibitors is dependent on protein synthesis.
Drexler HC; Euler M
Apoptosis; 2005 Aug; 10(4):743-58. PubMed ID: 16133866
[TBL] [Abstract][Full Text] [Related]
7. Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
Mori S; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 2002 Apr; 20(4):819-26. PubMed ID: 11894131
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
[TBL] [Abstract][Full Text] [Related]
9. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways.
Aoyama M; Kotani J; Usami M
Nutrition; 2010 Jun; 26(6):653-61. PubMed ID: 20004081
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
12. Sodium butyrate induced keratinocyte apoptosis.
Daehn IS; Varelias A; Rayner TE
Apoptosis; 2006 Aug; 11(8):1379-90. PubMed ID: 16761108
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
[TBL] [Abstract][Full Text] [Related]
14. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
16. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG
Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis.
Fluhr H; Krenzer S; Stein GM; Stork B; Deperschmidt M; Wallwiener D; Wesselborg S; Zygmunt M; Licht P
J Cell Sci; 2007 Dec; 120(Pt 23):4126-33. PubMed ID: 18003704
[TBL] [Abstract][Full Text] [Related]
19. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.
Nakata S; Yoshida T; Horinaka M; Shiraishi T; Wakada M; Sakai T
Oncogene; 2004 Aug; 23(37):6261-71. PubMed ID: 15208660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]